Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tapentadol Prolonged Release Versus Strong Opioids for Severe, Chronic Low Back Pain: Results of an Open-Label, Phase 3b Study
Authors
Keywords
Chronic pain, Equianalgesic, Equipotency, Low back pain, Neuropathic pain, Opioid, Severe pain, Tapentadol
Journal
ADVANCES IN THERAPY
Volume 30, Issue 3, Pages 229-259
Publisher
Springer Nature
Online
2013-03-09
DOI
10.1007/s12325-013-0015-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The international CHANGE PAIN physician survey: does specialism influence the perception of pain and its treatment?
- (2012) G. Varrassi et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effectiveness and safety of tapentadol prolonged release for severe, chronic low back pain with or without a neuropathic pain component: results of an open-label, phase 3b study
- (2012) Ilona Steigerwald et al. CURRENT MEDICAL RESEARCH AND OPINION
- Synergistic Interaction between the Two Mechanisms of Action of Tapentadol in Analgesia
- (2011) W. Schroder et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Efficacy and safety of tapentadol prolonged release for chronic osteoarthritis pain and low back pain
- (2010) Bernd Lange et al. ADVANCES IN THERAPY
- Efficacy and Safety of Tapentadol Extended Release Compared with Oxycodone Controlled Release for the Management of Moderate to Severe Chronic Pain Related to Osteoarthritis of the Knee
- (2010) Marc Afilalo et al. CLINICAL DRUG INVESTIGATION
- Patient and physician perceptions of treatment of moderate-to-severe chronic pain with oral opioids
- (2010) L. Duensing et al. CURRENT MEDICAL RESEARCH AND OPINION
- Safety and efficacy of tapentadol ER in patients with painful diabetic peripheral neuropathy: results of a randomized-withdrawal, placebo-controlled trial
- (2010) Sherwyn Schwartz et al. CURRENT MEDICAL RESEARCH AND OPINION
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
- (2010) N. Attal et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study
- (2010) Robert Buynak et al. EXPERT OPINION ON PHARMACOTHERAPY
- Importance of Side Effects in Opioid Treatment: A Trade-Off Analysis With Patients and Physicians
- (2010) Razmic S. Gregorian et al. JOURNAL OF PAIN
- Long-term Safety and Tolerability of Tapentadol Extended Release for the Management of Chronic Low Back Pain or Osteoarthritis Pain
- (2010) James E. Wild et al. Pain Practice
- Opioid switching and rotation in primary care: implementation and clinical utility
- (2009) Neal E. Slatkin CURRENT MEDICAL RESEARCH AND OPINION
- The evaluation of neuropathic components in low back pain
- (2009) Rainer Freynhagen et al. Current Pain and Headache Reports
- Nausea and Vomiting Side Effects with Opioid Analgesics during Treatment of Chronic Pain: Mechanisms, Implications, and Management Options
- (2009) Frank Porreca et al. PAIN MEDICINE
- The Prevalence, Severity, and Impact of Opioid-Induced Bowel Dysfunction: Results of a US and European Patient Survey (PROBE 1)
- (2008) Timothy J. Bell et al. PAIN MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started